Ticker Details
Organon & Co..
IPO Date:	May 14, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - General
Market Cap:	$1.8B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.33 | 1.72%
Avg Daily Range (30 D):	$0.19 | 2.96%
Avg Daily Range (90 D):	$0.17 | 2.38%

Institutional Daily Volume
Avg Daily Volume:	2.61M
Avg Daily Volume (30 D):	4.05M
Avg Daily Volume (90 D):	4.32M

Trade Size
Avg Trade Size (Sh.):	106
Avg Trade Size (Sh.) (30 D):	145
Avg Trade Size (Sh.) (90 D):	140

Institutional Trades
Total Institutional Trades:	4,186
Avg Institutional Trade:	$3.49M
Avg Institutional Trade (30 D):	$3.04M
Avg Institutional Trade (90 D):	$3.07M
Avg Institutional Trade Volume:	.19M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$7.74M
Avg Closing Trade (30 D):	$4.51M
Avg Closing Trade (90 D):	$5.28M
Avg Closing Volume:	429.18K

News

Apr 10, 2026 @ 2:57 PM Sun Pharma Nears Final Offer For Organon In Larges... Source: Vandana Singh

Mar 20, 2026 @ 9:22 PM Does This $25 Million Bet on a Stock Down 61% Sign... Source: Jonathan Ponciano

Mar 3, 2026 @ 9:49 AM KDventures announces that Organon has discontinued... Source: Kdventures Ab

Mar 3, 2026 @ 9:49 AM KDventures meddelar att Organon har avbrutit utvec... Source: Na

Jan 20, 2026 @ 3:31 PM Sun Pharma Eyes Organon In What Could Be India Pha... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.72	$-.79	$.72
Diluted EPS	$.72	$-.78	$.72
Revenue	$6.22B	$1.51B	$6.22B
Gross Profit	$3.31B	$741M	$3.31B
Net Income / Loss	$187M	$-205M	$187M
Operating Income / Loss	$425M	$-148M	$425M
Cost of Revenue	$2.9B	$766M	$2.9B
Net Cash Flow	$-101M	$-98M	$-101M
PE Ratio	12.51